VM-1500

DRUG3 trials

Sponsors

Viriom

Conditions

HIV-1-infectionHIV-infection

Phase 1

Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy Volunteers

CompletedNCT02489435

ViriomHIV-infection

Start: 2012-07-31End: 2013-06-30Updated: 2015-07-03

Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500

CompletedNCT02489487

ViriomHIV-infection

Start: 2014-09-30End: 2014-10-31Updated: 2018-10-04

Phase 2

Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy

CompletedNCT02489461

ViriomHIV-1-infection

Start: 2014-08-05End: 2017-09-18Updated: 2018-09-25